| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.767 | 31.861 | 51.288 | 66.210 | 71.118 | 81.745 | 92.756 | 105.844 | 127.089 |
| Total Income - EUR | - | 2.767 | 31.861 | 51.288 | 66.948 | 74.311 | 81.746 | 92.757 | 106.361 | 127.552 |
| Total Expenses - EUR | - | 4.076 | 20.155 | 23.671 | 25.251 | 30.527 | 28.072 | 32.445 | 41.079 | 58.944 |
| Gross Profit/Loss - EUR | - | -1.309 | 11.707 | 27.618 | 41.697 | 43.785 | 53.674 | 60.312 | 65.282 | 68.609 |
| Net Profit/Loss - EUR | - | -1.337 | 11.388 | 27.105 | 41.027 | 43.124 | 53.069 | 59.403 | 64.293 | 64.859 |
| Employees | - | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Andomed Biofam Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 130 | 0 | 0 | 44 | 94 | 796 | 687 | 48.753 | 38.988 |
| Current Assets | - | 1.171 | 11.297 | 39.529 | 42.952 | 47.945 | 54.559 | 62.364 | 55.219 | 59.944 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 66 | 127 | 702 | 503 | 215 | 438 | 44.276 | 47.310 | 48.774 |
| Cash | - | 1.105 | 11.170 | 38.827 | 42.448 | 47.730 | 54.120 | 18.088 | 7.909 | 11.170 |
| Shareholders Funds | - | -1.292 | 10.118 | 37.037 | 41.098 | 43.183 | 53.126 | 59.451 | 64.341 | 64.907 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.594 | 1.179 | 2.491 | 1.898 | 4.856 | 2.229 | 3.600 | 39.631 | 34.025 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Andomed Biofam Srl